| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |